Hypera Management

Mr. Breno Toledo Pires De Oliveira serves as Chief Executive Officer and Director of Hypera S.A. Previously, he served as Chief Financial Officer and Investor Relations Officer at HYPERA S.A. (formerly kno...

Hypera Management

Management criteria checks 0/4

Key information

Recent management updates

Hypera S.A., Annual General Meeting, Apr 23, 2024

Less than half of directors are independent

Less than half of directors are independent

Hypera S.A., Annual General Meeting, Apr 26, 2022

Recent updates

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 21% undervalued after recent price drop

Hypera S.A., Annual General Meeting, Apr 23, 2024

Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Is Hypera (BVMF:HYPE3) A Risky Investment?

Hypera S.A. to Report Q3, 2024 Results on Nov 06, 2024

Here's Why Hypera (BVMF:HYPE3) Has Caught The Eye Of Investors

Hypera S.A.'s (BVMF:HYPE3) Business Is Yet to Catch Up With Its Share Price

Hypera (BVMF:HYPE3) Has A Somewhat Strained Balance Sheet

Third quarter 2023 earnings: EPS exceeds analyst expectations

Now 21% undervalued after recent price drop

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

New major risk - Financial position

Second quarter 2023 earnings released: EPS: R$0.79 (vs R$0.72 in 2Q 2022)

Is Hypera (BVMF:HYPE3) A Risky Investment?

First quarter 2023 earnings released

We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

With EPS Growth And More, Hypera (BVMF:HYPE3) Makes An Interesting Case

Full year 2022 earnings released: EPS: R$2.69 (vs R$2.56 in FY 2021)

Hypera S.A. to Report Q4, 2022 Results on Feb 16, 2023

We Think Hypera (BVMF:HYPE3) Can Stay On Top Of Its Debt

Less than half of directors are independent

Third quarter 2022 earnings released

Is Now The Time To Put Hypera (BVMF:HYPE3) On Your Watchlist?

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Hypera S.A. (BVMF:HYPE3) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Is Hypera (BVMF:HYPE3) Using Too Much Debt?

Hypera Reportedly in Merger Talks with Grupo NC

Hypera S.A. to Report Q3, 2022 Results on Oct 28, 2022

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

First quarter 2022 earnings: Revenues in line with analyst expectations

Less than half of directors are independent

Hypera S.A. to Report Q1, 2022 Results on Apr 28, 2022

Here's Why Hypera (BVMF:HYPE3) Can Manage Its Debt Responsibly

Hypera S.A., Annual General Meeting, Apr 26, 2022

I Ran A Stock Scan For Earnings Growth And Hypera (BVMF:HYPE3) Passed With Ease

Subdued Growth No Barrier To Hypera S.A.'s (BVMF:HYPE3) Price

Full year 2021 earnings: EPS exceeds analyst expectations

Hypera S.A. to Report Fiscal Year 2021 Results on Feb 24, 2022

Hypera S.A.(BOVESPA:HYPE3) dropped from Brazil Valor BM&FBOVESPA Index

Third quarter 2021 earnings released: EPS R$0.73 (vs R$0.56 in 3Q 2020)

Second quarter 2021 earnings released

First quarter 2021 earnings released: EPS R$0.48 (vs R$0.39 in 1Q 2020)

New 90-day low: R$30.52

Full year 2020 earnings released

Revenue and earnings beat expectations

Hypera S.A. to Report Q4, 2020 Results on Feb 26, 2021

New 90-day high: R$35.31

New 90-day high: R$32.34

Market bids up stock over the past week

New 90-day low: R$28.80

Third quarter earnings released

Third-quarter earnings released: Revenue and earnings beat expectations

New 90-day low: R$30.22

Hypera S.A. (BOVESPA:HYPE3) completed the acquisition of Boehringer Ingelheim Buscopan brand and other assets from Boehringer Ingelheim International Gmbh, Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda. and Boehringer Ingelheim Pharma GmbH & Co. KG.

New 90-day low - R$31.65

Bunge Alimentos S.A. acquired Food division of Hypera S.A. (BOVESPA:HYPE3) for BRL 180 million.

New 90-day high - R$36.25

CEO

Tenure